Metraipolis › archive › dc_94b10daafe10
Real-World Outcomes of Primary Versus Interval Debulking Surgery in a Multicenter Cohort of Advanced Ovarian Cancer Patients Treated with Bevacizumab — Europe PMC PMID:41827739
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41827739
- DOI
- 10.3390/cancers18050805
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T10:05:03.052Z
- SHA-256 of the archived text
e6bad7f0c74e1f794367f698aa13530dd4cbc872e15df70856b9d4dbff35bfe6- Stable URL of this page
https://metraipolis.com/documento/dc_94b10daafe10
How to cite
Real-World Outcomes of Primary Versus Interval Debulking Surgery in a Multicenter Cohort of Advanced Ovarian Cancer Patients Treated with Bevacizumab — Europe PMC PMID:41827739 — Europe PMC (en), https://europepmc.org/article/MED/41827739 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_94b10daafe10 (Metraipolis archive dc_94b10daafe10, sha256 e6bad7f0c74e1f794367f698aa13530dd4cbc872e15df70856b9d4dbff35bfe6)
BibTeX
@misc{dc94b10daafe10,
title = {Real-World Outcomes of Primary Versus Interval Debulking Surgery in a Multicenter Cohort of Advanced Ovarian Cancer Patients Treated with Bevacizumab — Europe PMC PMID:41827739},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41827739},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_94b10daafe10; sha256 e6bad7f0c74e1f794367f698aa13530dd4cbc872e15df70856b9d4dbff35bfe6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41827739. Agents can read the archived copy with the MCP tool read_document.